Related Experiment Video
Updated: Jul 28, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Correlation between hepatitis B virus DNA levels and diagnostic tests for HBsAg, HBeAg, and PreS1-Ag in chronic
1Clinical Laboratory Center, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Insights
Serum HBsAg is a poor predictor of hepatitis B virus (HBV) replication. Co-detection of HBeAg and PreS1-Ag offers a more reliable method for diagnosing and managing chronic hepatitis B (CHB) patients.
Area of Science:
- Hepatology
- Virology
- Clinical Diagnostics
Background:
- Chronic hepatitis B (CHB) affects millions globally, necessitating accurate methods for monitoring viral activity.
- Hepatitis B virus (HBV) DNA levels are crucial for assessing viral replication and guiding treatment decisions.
- Current diagnostic markers like HBsAg and HBeAg have limitations in precisely quantifying HBV DNA.
Purpose of the Study:
- To evaluate the diagnostic value of serum HBsAg, HBeAg, and PreS1-Ag in quantifying HBV DNA levels in CHB patients.
- To determine the correlation between these serum markers and HBV DNA replication.
- To identify optimal markers for predicting HBV DNA levels in CHB.
Main Methods:
- Recruitment of 1000 CHB patients.
- Detection of serum HBsAg and HBeAg using electrochemiluminescence immunoassay.
- Quantification of PreS1-Ag by ELISA and HBV DNA by fluorescence quantitative PCR.
Main Results:
- A low correlation was observed between HBsAg and HBV DNA (r = 0.172), which strengthened at high HBV DNA levels (log10 > 7, r = 0.597).
- HBsAg and HBV DNA showed a significant positive correlation in HBeAg-positive patients (r = 0.321) but not in HBeAg-negative patients (r = -0.016).
- HBV DNA expression correlated significantly with HBeAg (χ2 = 83.07) and PreS1-Ag (χ2 = 36.01). The HBV DNA-positive rate was highest in patients positive for both HBeAg and PreS1-Ag (72.26%).
Conclusions:
- Serum HBsAg is not a reliable marker for predicting HBV replication.
- Co-detection of HBeAg and PreS1-Ag provides a more accurate prediction of HBV DNA replication.
- Combined HBeAg and PreS1-Ag detection is a valuable method for clinical diagnosis and treatment management of CHB.
Abstract:
The aim of this study was to investigate the diagnostic value of the serum markers HBsAg and HBeAg and PreS1 protein (PreS1-Ag) in quantifying the levels of hepatitis B virus (HBV) DNA in patients with chronic hepatitis B (CHB). One thousand CHB patients were recruited from Beijing You'an Hospital between June and December 2012. Serum HBsAg and HBeAg levels were detected by electrochemiluminescence immunoassay. Enzyme-linked immunosorbent assay and fluorescence quantitative PCR were used to determine the level of PreS1-Ag and HBV DNA, respectively. We observed a low correlation between HBsAg and HBV DNA (r = 0.172, P < 0.001) expression; however, the correlation coefficient increased gradually with the increase in HBV DNA levels, and was more significant when HBV DNA log10 > 7 (r = 0.597, P < 0.001). Additionally, HBsAg and HBV DNA showed a significant positive correlation in the HBeAg+ group (r = 0.321, P < 0.001), whereas no correlation was observed in the HBeAg- group (r = -0.016, P = 0.825). HBV DNA expression was correlated with HBeAg (χ2 = 83.07, P < 0.001) and PreS1-Ag (χ2 = 36.01, P < 0.001). HBV DNA-positive rate was higher in HBeAg/PreS1-Ag++ patients (72.26%) than that in the single-positive groups (P < 0.001). Therefore, serum HBsAg is not a good marker for the prediction of HBV replication, and co-detection of HBeAg and PreS1-Ag, which can better predict HBV DNA replication, can be used as a reliable method for the clinical diagnosis and treatment of CHB.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction

